Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 292,500
-3,500 (-1.18%)
At close: Jul 18, 2025, 3:30 PM KST
Hanmi Pharm. Company Description
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases.
The company’s products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED).
The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers.
The company was founded in 1973 and is based in Hwaseong-si, South Korea.
Hanmi Pharm. Co., Ltd.
| Country | South Korea |
| Founded | 1973 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,330 |
| CEO | Jae-Hyun Park |
Contact Details
Address: 214 Muha-ro Hwaseong-si, 18536 South Korea | |
| Phone | 82 3 1350 5600 |
| Website | hanmipharm.com |
Stock Details
| Ticker Symbol | 128940 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7128940004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae-Hyun Park | Chief Executive Officer and Director |
| Lim Chong-Yoon | President of Business Development and Executive Director |
| Jong-Soo Woo Ph.D. | Executive Director |
| Jong-Hoon Lim | CSR Executive Director |
| Jong-Hoon Lim | Executive Director and Management Planning /CIO |
| Chang-Ju Choi | Vice President of Information Management Team |